New York State Teachers Retirement System Reduces Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• New York State Teachers Retirement System trimmed its stake in UnitedHealth Group by 3.6% in Q4, selling 27,163 shares and leaving it with 723,490 shares valued at about $238.8 million (≈0.08% of the company).
• Meanwhile, several large institutions including Vanguard, Capital World Investors, Capital International, Capital Research and Dodge & Cox materially increased their UNH holdings, and overall institutional ownership stands at 87.86%.
• UnitedHealth posted a solid Q1 beat (EPS $7.23 vs. $6.76 expected; revenue $111.65B) with an upgraded outlook, rising analyst price targets, and a quarterly dividend of $2.21 (≈2.4% yield), supporting the positive near-term investor sentiment.

New York State Teachers Retirement System decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 723,490 shares of the healthcare conglomerate's stock after selling 27,163 shares during the period. New York State Teachers Retirement System owned about 0.08% of UnitedHealth Group worth $238,831,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate's stock worth $30,238,162,000 after acquiring an additional 995,210 shares in the last quarter. Capital World Investors lifted its position in shares of UnitedHealth Group by 18.8% during the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock worth $7,516,107,000 after acquiring an additional 3,439,182 shares in the last quarter. Capital International Investors lifted its position in shares of UnitedHealth Group by 11.1% during the third quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate's stock worth $6,042,710,000 after acquiring an additional 1,747,337 shares in the last quarter. Capital Research Global Investors lifted its position in shares of UnitedHealth Group by 126.9% during the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock worth $4,503,419,000 after acquiring an additional 7,293,009 shares in the last quarter. Finally, Dodge & Cox increased its holdings in shares of UnitedHealth Group by 8.6% in the third quarter. Dodge & Cox now owns 9,505,636 shares of the healthcare conglomerate's stock worth $3,282,296,000 after purchasing an additional 755,076 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Company posted a strong Q1 with margin improvement and an upgraded outlook, which investors view as evidence the turnaround is underway. UnitedHealth Stock Surges on Q1
• Positive Sentiment: JPMorgan raised its price target and kept an overweight stance, underpinning upside expectations from Wall Street. JPMorgan PT Raise
• Positive Sentiment: Erste Group increased its FY2026–FY2027 EPS estimates, signaling improving analyst confidence in earnings recovery.
• Positive Sentiment: UnitedHealth agreed to acquire Alegeus (benefits/consumer-directed accounts tech), aligning with management’s push into benefits technology and digital services — a strategic growth lever. Alegeus Acquisition
• Positive Sentiment: Management highlighted pricing discipline, digital adoption and operational fixes on the Q1 call — factors that could sustain margin improvement going forward. Q1 Earnings Call Takeaways
• Positive Sentiment: Multiple bullish commentaries and analyst pieces argue UNH may be at the start of a comeback, supporting positive investor sentiment. Bullish Opinion Piece
• Neutral Sentiment: UNH is a trending stock on retail/analyst screens — increased attention can boost volume but doesn’t guarantee directional conviction. Zacks Trending Note
• Neutral Sentiment: Macro/sector commentary (e.g., Jim Cramer suggesting healthcare as a defensive hedge) can attract allocation flows into the sector broadly but is not UNH-specific. Jim Cramer Healthcare Note
• Negative Sentiment: Peer strength: Humana and Centene reported beats/strong premiums this quarter — investor appetite for other insurers' outperformance could limit UNH’s relative rerating. Humana Q1 Beat Centene / Einhorn
• Negative Sentiment: Relative valuation pressure: CVS is trading at a much lower forward multiple, and narrative around CVS’s improving outlook could divert value-focused investors away from UNH. CVS Valuation Article

UnitedHealth Group Price Performance

UNH traded down $2.52 during trading on Thursday, reaching $368.22. The stock had a trading volume of 1,352,200 shares, compared to its average volume of 9,569,383. The stock has a market cap of $334.42 billion, a PE ratio of 27.86, a PEG ratio of 1.53 and a beta of 0.40. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.80. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $411.99. The business has a 50-day moving average of $297.82 and a 200-day moving average of $317.00.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts' consensus estimates of $6.76 by $0.47. The business had revenue of $111.65 billion for the quarter, compared to analysts' expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm's revenue was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, March 9th. UnitedHealth Group's dividend payout ratio is presently 66.77%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company's stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.28% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the topic of several research analyst reports. Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $405.00 to $411.00 and gave the stock an "outperform" rating in a report on Tuesday, April 7th. JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $389.00 to $420.00 and gave the stock an "overweight" rating in a report on Tuesday. KeyCorp reaffirmed an "overweight" rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Evercore raised shares of UnitedHealth Group to a "strong-buy" rating in a report on Tuesday, January 6th. Finally, Raymond James Financial raised shares of UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 price target on the stock in a report on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $378.88.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.